Antares Pharma/ US0366421065 /
2022-05-23 12:00:00 AM | Chg. - | Volume | Bid12:00:00 AM | Ask12:00:00 AM | High | Low |
---|---|---|---|---|---|---|
5.5900USD | - | 2.71 mill. Turnover: - |
5.5900Bid Size: - | 5.6000Ask Size: - | 5.6000 | 5.5800 |
GlobeNewswire
2022-03-29
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement The...
GlobeNewswire
2022-03-03
Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results
GlobeNewswire
2022-02-17
Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results
GlobeNewswire
2022-01-18
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
GlobeNewswire
2022-01-11
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
GlobeNewswire
2021-12-15
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combinati...
GlobeNewswire
2021-11-22
Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GlobeNewswire
2021-10-28
Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors
GlobeNewswire
2021-10-25
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
GlobeNewswire
2021-10-21
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
GlobeNewswire
2021-10-18
Antares Pharma Enters into Exclusive License Agreement With Lipocine for TLANDO® in U.S.
GlobeNewswire
2021-10-12
Galera Appoints Mark J. Bachleda as Chief Commercial Officer and Jennifer Evans Stacey as Chief Lega...
GlobeNewswire
2021-09-30
Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
GlobeNewswire
2021-09-08
Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-07-22
Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
GlobeNewswire
2021-07-07
Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare Conference